Dr. Reddy's Laboratories sells non-core dermatology brands

Dr. Reddy's Laboratories announced the signing of a deal to divest certain non-core brands of the company in the dermatology segments to Eris Lifesciences.

Under the agreement, Eris Lifesciences will be assigned the trademark of these brands by Dr. Reddy's for a consideration of Rs. 275 crore. As per IQVIA MAT December 2022, the divested portfolio saw sales of Rs. 60 crore in India.

Powered by Capital Market - Live News